$DCTH
Delcath Systems Inc

2022 Q3 Form 10-Q Financial Statement

#000119312522215053 Filed on August 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $906.0K $797.0K $378.0K
YoY Change 73.56% 48.69% -3.08%
Cost Of Revenue $235.0K $180.0K $33.00K
YoY Change 3.52% -10.89% -70.0%
Gross Profit $671.0K $617.0K $345.0K
YoY Change 127.46% 84.73% 23.21%
Gross Profit Margin 74.06% 77.42% 91.27%
Selling, General & Admin $4.519M $4.145M $3.648M
YoY Change 11.97% 26.06% 10.55%
% of Gross Profit 673.47% 671.8% 1057.39%
Research & Development $3.953M $5.456M $4.240M
YoY Change 33.77% 56.02% 14.29%
% of Gross Profit 589.12% 884.28% 1228.99%
Depreciation & Amortization $67.00K $0.00 $31.00K
YoY Change 81.08% -100.0% -22.5%
% of Gross Profit 9.99% 0.0% 8.99%
Operating Expenses $8.472M $9.601M $7.888M
YoY Change 21.18% 41.5% 12.52%
Operating Profit -$7.801M -$8.984M -$7.543M
YoY Change 16.5% 39.27% 12.08%
Interest Expense -$730.0K -$665.0K -$645.0K
YoY Change 73.81% 1562.5% 1512.5%
% of Operating Profit
Other Income/Expense, Net $26.00K -$8.000K -$15.00K
YoY Change -388.89% -113.11% -175.0%
Pretax Income -$8.505M -$9.657M -$8.203M
YoY Change 19.37% 50.19% 21.53%
Income Tax
% Of Pretax Income
Net Earnings -$8.505M -$9.657M -$8.203M
YoY Change 19.37% 50.19% 21.58%
Net Earnings / Revenue -938.74% -1211.67% -2170.11%
Basic Earnings Per Share -$0.92 -$1.18 -$1.10
Diluted Earnings Per Share -$0.92 -$1.18 -$1.002M
COMMON SHARES
Basic Shares Outstanding 8.598M 8.190M 8.190M
Diluted Shares Outstanding 9.216M 8.190M 8.190M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.831M $10.20M $16.34M
YoY Change -60.46% -47.06% -38.57%
Cash & Equivalents $9.831M $10.20M $16.34M
Short-Term Investments
Other Short-Term Assets $6.186M $6.521M $6.855M
YoY Change 0.65% 179.15% 183.26%
Inventory $1.926M $2.040M $2.011M
Prepaid Expenses
Receivables $537.0K $438.0K $178.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $18.48M $19.20M $25.38M
YoY Change -42.82% -16.17% -15.95%
LONG-TERM ASSETS
Property, Plant & Equipment $1.452M $1.457M $1.933M
YoY Change 5.22% 7.05% -8.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.746M $1.864M $1.933M
YoY Change -17.13% -7.31% -8.82%
TOTAL ASSETS
Total Short-Term Assets $18.48M $19.20M $25.38M
Total Long-Term Assets $1.746M $1.864M $1.933M
Total Assets $20.23M $21.07M $27.32M
YoY Change -41.25% -15.46% -15.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.632M $2.067M $1.243M
YoY Change 121.74% 68.87% 1.06%
Accrued Expenses $5.137M $5.417M $4.584M
YoY Change 57.14% 49.6% -27.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $79.00K $315.0K
YoY Change
Long-Term Debt Due $6.481M $4.474M $2.520M
YoY Change 26.0%
Total Short-Term Liabilities $14.45M $12.25M $8.662M
YoY Change 169.46% 113.41% -14.24%
LONG-TERM LIABILITIES
Long-Term Debt $9.727M $11.55M $13.31M
YoY Change -36.98% 477.35%
Other Long-Term Liabilities $1.299M $113.0K $122.0K
YoY Change -31.7% -94.4% -94.48%
Total Long-Term Liabilities $1.299M $11.66M $13.43M
YoY Change -92.51% 190.27% 507.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.45M $12.25M $8.662M
Total Long-Term Liabilities $1.299M $11.66M $13.43M
Total Liabilities $25.47M $23.91M $22.09M
YoY Change 12.22% 145.05% 79.46%
SHAREHOLDERS EQUITY
Retained Earnings -$447.3M -$438.8M
YoY Change 7.62%
Common Stock $86.00K $79.00K
YoY Change 16.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.246M -$2.846M $5.225M
YoY Change
Total Liabilities & Shareholders Equity $20.23M $21.07M $27.32M
YoY Change -41.25% -15.46% -15.48%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$8.505M -$9.657M -$8.203M
YoY Change 19.37% 50.19% 21.58%
Depreciation, Depletion And Amortization $67.00K $0.00 $31.00K
YoY Change 81.08% -100.0% -22.5%
Cash From Operating Activities -$5.179M -$6.037M -$6.375M
YoY Change 14.48% -14.96% 39.59%
INVESTING ACTIVITIES
Capital Expenditures -$68.00K -$52.00K -$89.00K
YoY Change 21.43% -33.33% 790.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$68.00K -$52.00K -$89.00K
YoY Change 21.43% -33.33% 888.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.896M 0.000 0.000
YoY Change -65.33% -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -5.179M -6.037M -6.375M
Cash From Investing Activities -68.00K -52.00K -89.00K
Cash From Financing Activities 4.896M 0.000 0.000
Net Change In Cash -351.0K -6.089M -6.464M
YoY Change -103.68% -15.01% 206.93%
FREE CASH FLOW
Cash From Operating Activities -$5.179M -$6.037M -$6.375M
Capital Expenditures -$68.00K -$52.00K -$89.00K
Free Cash Flow -$5.111M -$5.985M -$6.286M
YoY Change 14.39% -14.76% 37.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000872912
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16133
dei Entity Registrant Name
EntityRegistrantName
DELCATH SYSTEMS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-1245881
dei Entity Address Address Line1
EntityAddressAddressLine1
1633 Broadway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 22C
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6584000
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value per share
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
489-2100
dei Trading Symbol
TradingSymbol
DCTH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8597682
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10203000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22802000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4151000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4151000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
438000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44000
CY2022Q2 us-gaap Inventory Net
InventoryNet
2040000
CY2021Q4 us-gaap Inventory Net
InventoryNet
1412000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2370000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2743000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
19202000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
31152000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1457000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1348000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
407000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
624000
CY2022Q2 us-gaap Assets
Assets
21066000
CY2021Q4 us-gaap Assets
Assets
33124000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2067000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
638000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5417000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4109000
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
170000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
294000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
416000
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
4474000
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
621000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12252000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5954000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
113000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
207000
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
6838000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
10372000
CY2022Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
4709000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
4639000
CY2022Q2 us-gaap Liabilities
Liabilities
23912000
CY2021Q4 us-gaap Liabilities
Liabilities
21172000
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
11357
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
11357
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
11357
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
11357
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7906728
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7906728
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7906728
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7906728
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
79000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
79000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
435922000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
432831000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-438836000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-420976000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
18000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2846000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11952000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21066000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33124000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
180000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
202000
us-gaap Cost Of Revenue
CostOfRevenue
214000
us-gaap Cost Of Revenue
CostOfRevenue
314000
CY2022Q2 us-gaap Gross Profit
GrossProfit
617000
CY2021Q2 us-gaap Gross Profit
GrossProfit
334000
us-gaap Gross Profit
GrossProfit
960000
us-gaap Gross Profit
GrossProfit
610000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5456000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3497000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9696000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7204000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4145000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3288000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7791000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5225000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1617000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
9601000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
6785000
us-gaap Operating Expenses
OperatingExpenses
17487000
us-gaap Operating Expenses
OperatingExpenses
13788000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8984000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6451000
us-gaap Operating Income Loss
OperatingIncomeLoss
-16527000
us-gaap Operating Income Loss
OperatingIncomeLoss
-13178000
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-665000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-40000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1309000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-81000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
61000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
82000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9657000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6430000
us-gaap Net Income Loss
NetIncomeLoss
-17860000
us-gaap Net Income Loss
NetIncomeLoss
-13177000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-31000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-61000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-29000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
33000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9688000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6491000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17889000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13144000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.18
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.18
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8190483
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8190483
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6681369
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6681369
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8190483
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8190483
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6589655
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6589655
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11952000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1474000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8203000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9657000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2846000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22078000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2148000
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
57000
CY2021Q1 dcth Stock Issued During Period Value Exercise Of Warrants For Common Stock
StockIssuedDuringPeriodValueExerciseOfWarrantsForCommonStock
2376000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6747000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
94000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
20006000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1626000
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
CY2021Q2 dcth Stock Issued During Period Value Exercise Of Warrants For Common Stock
StockIssuedDuringPeriodValueExerciseOfWarrantsForCommonStock
17000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6430000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-61000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
15159000
us-gaap Net Income Loss
NetIncomeLoss
-17860000
us-gaap Net Income Loss
NetIncomeLoss
-13177000
dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
3091000
dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
3774000
us-gaap Depreciation
Depreciation
31000
us-gaap Depreciation
Depreciation
78000
dcth Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
234000
dcth Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
380000
us-gaap Paid In Kind Interest
PaidInKindInterest
80000
us-gaap Paid In Kind Interest
PaidInKindInterest
79000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-374000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-485000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
394000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
628000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
366000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2667000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2036000
dcth Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-217000
dcth Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-155000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-170000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-334000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12412000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11669000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
141000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-141000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2393000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2393000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-46000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12599000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9331000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26953000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28756000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14354000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19425000
CY2022Q2 us-gaap Cash
Cash
10203000
CY2021Q2 us-gaap Cash
Cash
19274000
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
4151000
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
151000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14354000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19425000
us-gaap Interest Paid Net
InterestPaidNet
842000
us-gaap Interest Paid Net
InterestPaidNet
4000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
9000
dcth Shares Settled For Services
SharesSettledForServices
57000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-438800000
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
909000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
767000
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1050000
CY2022Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
17638000
CY2021Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
150000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
800000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
42034
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.35
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2311393
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.42
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10203000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22802000
CY2022Q2 dcth Loan Agreement Restricted Cash
LoanAgreementRestrictedCash
4000000
CY2021Q4 dcth Loan Agreement Restricted Cash
LoanAgreementRestrictedCash
4000000
CY2022Q2 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
101000
CY2021Q4 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
101000
CY2022Q2 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2021Q4 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14354000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26953000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
645000
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
81000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0
CY2022Q2 us-gaap Inventory Net
InventoryNet
2040000
CY2021Q4 us-gaap Inventory Net
InventoryNet
1412000
CY2022Q2 dcth Prepaid Clinical Trial Expenses Current
PrepaidClinicalTrialExpensesCurrent
1630000
CY2021Q4 dcth Prepaid Clinical Trial Expenses Current
PrepaidClinicalTrialExpensesCurrent
1630000
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
400000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
890000
CY2022Q2 dcth Prepaid Professional Services Current
PrepaidProfessionalServicesCurrent
154000
CY2021Q4 dcth Prepaid Professional Services Current
PrepaidProfessionalServicesCurrent
15000
CY2022Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
186000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
208000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2370000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2743000
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
3774000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8000000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
us-gaap Operating Lease Cost
OperatingLeaseCost
234000
us-gaap Operating Lease Payments
OperatingLeasePayments
234000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
29116
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.73
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6311000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6173000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4854000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4825000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1457000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1348000
dcth Depreciation Expense
DepreciationExpense
65000
dcth Depreciation Expense
DepreciationExpense
78000
CY2022Q2 dcth Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
1500000
CY2021Q4 dcth Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
1517000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1228000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
893000
CY2022Q2 dcth Short Term Fnancing
ShortTermFnancing
79000
CY2021Q4 dcth Short Term Fnancing
ShortTermFnancing
551000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1977000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
603000
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
473000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
393000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
160000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
152000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5417000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4109000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.31
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
223000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
109000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
42000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
42000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
23000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
438000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
32000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
407000
CY2022Q2 dcth Notes And Loans Payable Gross Non Current
NotesAndLoansPayableGrossNonCurrent
7640000
CY2022Q2 dcth Discount On Notes And Loans Payable Nonurrent
DiscountOnNotesAndLoansPayableNonurrent
-802000
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
6838000
CY2021Q4 dcth Notes And Loans Payable Gross Non Current
NotesAndLoansPayableGrossNonCurrent
11924000
CY2021Q4 dcth Discount On Notes And Loans Payable Nonurrent
DiscountOnNotesAndLoansPayableNonurrent
-1552000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
10372000
CY2022Q2 dcth Notes And Loans Payable Gross
NotesAndLoansPayableGross
5000000
CY2022Q2 dcth Discount On Notes And Loans Payable
DiscountOnNotesAndLoansPayable
-291000
CY2022Q2 dcth Notes And Loans Payable Net
NotesAndLoansPayableNet
4709000
CY2021Q4 dcth Notes And Loans Payable Gross
NotesAndLoansPayableGross
5000000
CY2021Q4 dcth Discount On Notes And Loans Payable
DiscountOnNotesAndLoansPayable
-361000
CY2021Q4 dcth Notes And Loans Payable Net
NotesAndLoansPayableNet
4639000
dcth Percentage Of Final Payment Included In Gross Amount
PercentageOfFinalPaymentIncludedInGrossAmount
0.0425
dcth Final Payment
FinalPayment
638000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.87
CY2022Q2 us-gaap Loans Payable
LoansPayable
12638000
CY2022Q2 us-gaap Notes Payable
NotesPayable
5000000
dcth Avenue Warrant Value
AvenueWarrantValue
1300000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y25D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.87
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0077
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2475000
CY2020Q4 dcth Number Of Common Shares Remained Available To Be Issued
NumberOfCommonSharesRemainedAvailableToBeIssued
737417
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5DT20H
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.7833
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1732460
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
650083
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M12D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
952670
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.48
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y4M24D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2311393
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y4M24D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
952670
CY2022Q2 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
1473000
CY2021Q2 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
1626000
dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
3091000
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3894498
CY2021Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
9.27
dcth Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
0
dcth Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
0
dcth Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
0
dcth Class Of Warrant Or Right Weighted Average Exercise Price Exercises In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
0
dcth Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
0
dcth Class Of Warrant Or Right Weighted Average Exercise Price Expirations In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExpirationsInPeriod
0
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3894498
CY2022Q2 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
9.27
dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P2Y8M12D
CY2022Q2 dcth Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
3894498
CY2022Q2 dcth Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
9.27
dcth Class Of Warrant Or Right Exercisable Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractualTerm
P2Y8M12D
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3894498
dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P2Y8M12D
CY2022Q2 dcth Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
3894498
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7829643
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6190076
dcth Number Of Shares Pre Funded Penny Warrants Outstanding
NumberOfSharesPreFundedPennyWarrantsOutstanding
283755
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7906728
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6319622
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7906728
CY2021Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6511194
dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
283755
dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
270033
CY2022Q2 dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
283755
CY2021Q2 dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
170175
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8190483
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8190483
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6589655
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6589655
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8190483
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8190483
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6681369
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6681369
CY2022Q2 dcth Percentage Of Enrolled Patients
PercentageOfEnrolledPatients
0.87

Files In Submission

Name View Source Status
0001193125-22-215053-index-headers.html Edgar Link pending
0001193125-22-215053-index.html Edgar Link pending
0001193125-22-215053.txt Edgar Link pending
0001193125-22-215053-xbrl.zip Edgar Link pending
d263987d10q.htm Edgar Link pending
d263987dex311.htm Edgar Link pending
d263987dex312.htm Edgar Link pending
d263987dex321.htm Edgar Link pending
d263987dex3211.htm Edgar Link pending
dcth-20220630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
dcth-20220630_def.xml Edgar Link unprocessable
dcth-20220630_lab.xml Edgar Link unprocessable
dcth-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d263987d10q_htm.xml Edgar Link completed
dcth-20220630_cal.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending